NRG
DGX icon

Nemes Rush Group’s Quest Diagnostics DGX Stock Holding History

Nemes Rush Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Hold
7
– – ﹤0.01% 825
2026
Q1 		$1.37K Hold
7
– – ﹤0.01% 789
2025
Q4 		$1.22K Hold
7
– – ﹤0.01% 790
2025
Q3 		$1.33K Hold
7
– – ﹤0.01% 618
2025
Q2 		$1.26K Hold
7
– – ﹤0.01% 635
2025
Q1 		$1.18K Hold
7
– – ﹤0.01% 641
2024
Q4 		$1.06K Buy
+7
New +$1.09K ﹤0.01% 660

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Nemes Rush Group's DGX Position: Q2 2026 in Review

Nemes Rush Group held its Quest Diagnostics (DGX) position steady in Q2 2026 at 7 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #825.

Nemes Rush Group first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Nemes Rush Group held 7 shares of Quest Diagnostics worth $1.48K as of Q2 2026.
  • Nemes Rush Group left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #825 holding.
  • Nemes Rush Group first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.